A Clinical trial to study the effect of the drug Karpoora Silasathu Parpam in patients having Vathakalladaippu (Urolithiasis)

Phase II Non-randomized Open clinical evaluation of siddha medicine Karpoora Silasathu Parpam for Vathakalladaippu (Urolithiasis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027928

Enrollment

Registered

2020-09-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Karpoora silasathu parpam: 200mg of Karpoora silasathu parpam is administrated with tender coconut twice a day for 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Presence of calculi in USG(whole abdomen) Stone size 4-10mm Lower Abdominal Pain Flank Pain Dysuria Haematuria

Exclusion criteria

Exclusion criteria: Pregnant and Lactating mothers. Staghorn Calculus Calculi associated with elevated serum creatinine level Hydronephrosis Uric acid stone

Design outcomes

Primary

Measure	Time frame
It is mainly assessed by reduction in the size of stone in USG- whole abdomenTimepoint: 48 days	—

Secondary

Measure	Time frame
It is assessed by comparing the stone size before and after treatment.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactDr Mariachristina B

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026